(MedPage Today) — Novo Nordisk is chopping prices again for semaglutide (Wegovy), but doctors say the expense will remain challenging for patients without insurance.
The drugmaker said Monday that it has started selling higher doses of the injectable…
Source link : https://www.medpagetoday.com/primarycare/obesity/118568
Author :
Publish date : 2025-11-17 20:36:00
Copyright for syndicated content belongs to the linked Source.
